Companies similar to DESIGN THERAPEUTICS INC (DSGN)
Health Care · NASDAQ
DESIGN THERAPEUTICS INC (DSGN)'s closest peers include Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS), Sarepta Therapeutics (SRPT), WAVE LIFE SCIENCES LTD (WVE) and BEAM THERAPEUTICS INC (BEAM). This peer set is drawn from DSGN's enriched company profile and is informational only — not financial advice.
Similar companies
-
Alnylam PharmaceuticalsALNYHealth Care
Alnylam is a global leader in RNA interference therapeutics, pioneering a new class of genetic medicines to treat rare and serious diseases.
$271.37 (as of 2026-07-21) · market cap $36.2B
-
Ionis PharmaceuticalsIONSHealth Care
Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…
$53.39 (as of 2026-07-21) · market cap $8.8B
-
Sarepta TherapeuticsSRPTHealth Care
A biopharmaceutical leader in genetic medicine, specializing in innovative RNA-targeted therapies and gene treatments for Duchenne muscular dystrophy and rare…
$16.21 (as of 2026-07-21) · market cap $1.8B
-
WAVE LIFE SCIENCES LTDWVEHealth Care
A clinical-stage biotechnology company developing a versatile, multimodal RNA medicine platform to treat rare and common diseases without the need for complex…
$5.79 (as of 2026-07-21) · market cap $1.1B
-
BEAM THERAPEUTICS INCBEAMHealth Care
Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare…
$27.29 (as of 2026-07-21) · market cap $2.8B
Not quite? Describe exactly what you want →
Peers are drawn from DSGN's enriched profile (the same similarity signal the chat uses for "companies like DSGN"). See the full profile: DESIGN THERAPEUTICS INC (DSGN).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.